Skip to main content

Table 1 Patient characteristics

From: Point accuracy and reliability of an interstitial continuous glucose-monitoring device in critically ill patients: a prospective study

 

N = 50

N = 45

All included patients

Patients included in the point accuracy analysis

Age in years, median (IQR)

65 (56-72)

65 (55-72)

Male gender, number (%)

25 (50%)

24 (53%)

Race, number (%)

  

  Caucasian

45 (90%)

40 (89%)

  Black

4 (8%)

4 (9%)

  Asian

1 (2%)

1 (2%)

BMI in kg/m2, median (IQR)

24.7 (22.4-27.6)

24.4 (22.2-27.3)

Admission diagnosis, number (%)

  

  Medical

31 (62%)

26 (58%)

  Emergency surgery

11 (22%)

11 (24%)

  Planned surgery

8 (16%)

8 (18%)

Planned admission, number (%)

10 (20%)

9 (20%)

History of diabetes, number (%)

  

  No diabetes

39 (78%)

34 (76%)

  Diabetes, unknown treatment

2 (4%)

2 (4%)

  Diabetes treated with insulin

4 (8%)

4 (9%)

  Diabetes treated with oral agents

5 (10%)

5 (12%)

APACHE II score, median (IQR)

23 (17-26)

22 (17-25)

SAPS II, median (IQR)

46 (39-55)

46 (40-55)

ICU LOS in days, median (IQR)

9 (4-16)

11 (5-16)

Hospital LOS in days, median (IQR)

19 (10-35)

19 (11-35)

ICU mortality, number (%)

11 (22%)

10 (22%)

Hospital mortality, number (%)

15 (30%)

14 (31%)

  1. APACHE II, Acute Physiology and Chronic Health Evaluation II; BMI, body mass index; ICU, intensive care unit; IQR, interquartile range; LOS, length of stay; SAPS II, Simplified Acute Physiology Score II.